White Guide and Orange Guide Formatting Project - Pfizer

More documents

Recommendations

Info

Orange Guide – Chapter 4: Federal Employee Interactions and Lobbying In addition, federal and state anti-bribery laws impose criminal penalties for offering gifts or campaign contributions to government officials in exchange for a change in policy, entering into a federal or state contract, or agreeing to engage in any other official act. For this reason, you are prohibited from discussing past, present or future campaign contributions with a government official or public employee. The Pfizer Political Action Committee Corporations are not allowed to make direct contributions to any candidates running for federal office, and similar restrictions may apply in certain states as well. However, corporations can sponsor political action committees (PACs), which are supported by voluntary contributions from eligible employees. These corporate-sponsored PACs can then contribute directly to candidates running for federal office and for state office where applicable. A PAC is subject to federal laws and regulations, reporting requirements and monetary limits on campaign contributions. Pfizer sponsors a PAC. The Pfizer PAC is a non-partisan PAC that supports candidates who value biopharmaceutical innovation and are open to real dialogue on issues that affect patient access to medicines. For more information on the Pfizer PAC, please visit www.epacweb.com/Pfizer. Before interacting with any federal or state government official or public employee in a way not described here, seek guidance from a GRD or your team attorney. FOR MORE INFORMATION Lobbying questions may be referred to the relevant GRD or team attorney. For more information on state specific laws, see the State Laws: HCP and State Employee Restrictions Chapter. For more information on Pfizer’s HCP Payment Disclosure Policy, see the Meals, Educational Items and HCP Payment Disclosure Chapter. For more information on Pfizer’s educational grant process, see the Support of External Organizations Chapter. 94 Rev. 09/12 Page 24 of 25
Orange Guide – Chapter 4: Federal Employee Interactions and Lobbying For more information about the Pfizer PAC, visit www.epacweb.com/Pfizer. Take the online training module on how to complete the federal Lobbying Disclosure form. Federal Employee Interaction questions may be referred to your lead BU National Account Manager or team attorney. For more information regarding on-site activities at VA facilities, see the March 2012 Legally Speaking article found on the Compliance page of PfieldNet. 95 Rev. 09/12 Page 25 of 25
Page 1 and 2:
Dear Colleagues: Pfizer Inc 235 Eas
Page 3 and 4:
To expand the bookmarks for a chapt
Page 5 and 6:
Orange Guide - Chapter 1: Overview
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Foreign Corrupt Practices Act Orang
Page 17 and 18:
Pfizer’s Corporate Integrity Agre
Page 19 and 20:
Page 21 and 22:
Orange Guide - Chapter 2: Detailing
Page 23 and 24:
Key Points to Ensure Compliance Ora
Page 25 and 26:
Page 27 and 28:
Communicating Formulary Status Mail
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Hospital Protocols Comparative Clai
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Interacting with RMRS Colleagues Or
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48: Detailing at Journal Club Meetings
Page 49 and 50: Orange Guide - Chapter 3: Support o
Page 55 and 56: Medical Education Grants Overview O
Page 57 and 58: International Grant Activity Orange
Page 61 and 62: “Not-for-Profit” Defined Orange
Page 67 and 68: Information on Pfizer’s External
Page 69 and 70: Overview Orange Guide - Chapter 3:
Page 71 and 72: Awards, Scholarships and Fellowship
Page 75 and 76: Orange Guide - Chapter 4: Federal E
Page 81 and 82: Promotional Activities Orange Guide
Page 85 and 86: Speaker Program Meals Part-Time VA
Page 97: Orange Guide - Chapter 4: Federal E
Page 101 and 102: Orange Guide - Chapter 5: Interacti
Page 115 and 116: Discussing Payer Rebates Medical Ac
Page 119 and 120: Orange Guide - Chapter 6: Clinical
Page 127 and 128: Orange Guide - Chapter 7: P&T Commi
Page 131 and 132: Questions From a P&T Committee Memb
Page 139 and 140: Orange Guide - Chapter 8: Privacy:
Page 145 and 146: Seek Only De-Identified Data Orange
Page 147 and 148: Consent Forms and Mentorships Orang
Page 149 and 150:
REMEMBER Orange Guide - Chapter 8:
Page 151 and 152:
Proper Use of HCP Prescriber Data O
Page 153 and 154:
Orange Guide - Chapter 8: Privacy:
Page 155 and 156:
Orange Guide - Chapter 8: Privacy:
Page 157 and 158:
Orange Guide - Chapter 9: Speaker P
Page 159 and 160:
Page 161 and 162:
Speaker Selection Scheduling Issues
Page 163 and 164:
Use of Pfizer Approved Speaker Slid
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Providing In-Office Meals to Office
Page 171 and 172:
U.S. HCP Payment Disclosure Policy
Page 173 and 174:
Page 175 and 176:
Closeouts Orange Guide - Chapter 9:
Page 177 and 178:
Page 179 and 180:
Physical Separation of Speaker Prog
Page 181 and 182:
Chapter 10: STARTERS CONTENTS Start
Page 183 and 184:
Page 185 and 186:
Orange Guide - Chapter 10: Starters
Page 187 and 188:
Inclusion of Materials with Starter
Page 189 and 190:
Page 191 and 192:
Distribution of Starters to Colleag
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Orange Guide - Chapter 11: Patient
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
A special note about Medicare Part
Page 207 and 208:
Refer any questions to your team at
Page 209 and 210:
Chapter 12: CONTRACTING Introductio
Page 211 and 212:
Orange Guide - Chapter 12: Contract
Page 213 and 214:
Orange Guide - Chapter 12: Contract
Page 215 and 216:
Page 217 and 218:
Chapter 13: HEALTH SCREENINGS Intro
Page 219 and 220:
Orange Guide - Chapter 13: Health S
Page 221 and 222:
If organized by Pfizer: Orange Guid
Page 223 and 224:
Orange Guide - Chapter 13: Health S
Page 225 and 226:
Orange Guide - Chapter 14: CGC Tool
Page 227 and 228:
Orange Guide - Chapter 14: CGC Tool
Page 229 and 230:
Discussing Pfizer Products While Me
Page 231 and 232:
Orange Guide - Chapter 15: Non-Reba
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Orange Guide - Chapter 16: Consumer
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Providing Food to Consumers at a Di
Page 245 and 246:
Page 247 and 248:
Content of Consumer Slide Decks Att
Page 249 and 250:
Adverse Events Orange Guide - Chapt
Page 251 and 252:
Orange Guide - Chapter 17: State La
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
California Orange Guide - Chapter 1
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Educational Items Orange Guide - Ch
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Orange Guide - Chapter 18: Meals, E
Page 291 and 292:
Page 293 and 294:
Meals to HCPs Orange Guide - Chapte
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Orange Guide - Chapter 19: Sales Ac
Page 313 and 314:
Pricing Considerations Orange Guide
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321:
show all

White Guide and Orange Guide Formatting Project - Pfizer

Create successful ePaper yourself

Delete template?

Save as template?